Does nitric oxide inhalation need to be reassessed?
Keyword(s):
Background: Inhaled nitric oxide is a drug which has been given FDA approval in 1999 but was not found prior to approval to be safe for use in premature neonates. Aim: To review and assess the studies which was done prior to its approval in order to find out what evidences the approval by the FDA was based on. Methods: A thorough search of the electronic data-base, Medline, Embase, Cinahl, Google. Conclusion: The use of this drug in treatment of the Pulmonary hypertension in premature babies is still contraversial and hold a serious untoward effects on the health, it should only used as the last ditch.
1994 ◽
Vol 8
(5)
◽
pp. 13
1999 ◽
Vol 31
(6)
◽
pp. 2505-2506
◽
Keyword(s):
1993 ◽
Vol 233
(1)
◽
pp. 85-94
◽
Keyword(s):
1999 ◽
Vol 14
(3)
◽
pp. 133-140
◽